Global Gastrointestinal Stromal Tumor Drug Market Research Report 2026(Status and Outlook)
The global Gastrointestinal Stromal Tumor Drug market size was estimated at USD 1250.45 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumor Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumor Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumor Drug market.
Global Gastrointestinal Stromal Tumor Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Mylan Pharms Inc.
Bulat Pharmaceutical
MSN Laboratories
Vannsh Life Sciences
Beacon Pharmaceuticals
Drug International
Deciphera Pharmaceuticals
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals
Market Segmentation (by Type)
Imatinib
Sunitinib
Regorafenib
Ripretinib
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumor Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumor Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumor Drug market.
Global Gastrointestinal Stromal Tumor Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Mylan Pharms Inc.
Bulat Pharmaceutical
MSN Laboratories
Vannsh Life Sciences
Beacon Pharmaceuticals
Drug International
Deciphera Pharmaceuticals
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals
Market Segmentation (by Type)
Imatinib
Sunitinib
Regorafenib
Ripretinib
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Stromal Tumor Drug Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumor Drug Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumor Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumor Drug Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumor Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumor Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumor Drug Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumor Drug Market Size by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumor Drug Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor Drug Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumor Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumor Drug Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumor Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumor Drug Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumor Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumor Drug Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumor Drug Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumor Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumor Drug by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumor Drug Production
9.4.1 North America Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumor Drug Production
9.5.1 Europe Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumor Drug Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumor Drug Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Gastrointestinal Stromal Tumor Drug Product Overview
10.1.3 Novartis Gastrointestinal Stromal Tumor Drug Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer Pharmaceuticals
10.2.1 Bayer Pharmaceuticals Basic Information
10.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.2.4 Bayer Pharmaceuticals Business Overview
10.2.5 Bayer Pharmaceuticals SWOT Analysis
10.2.6 Bayer Pharmaceuticals Recent Developments
10.3 Glenmark Pharmaceuticals Ltd.
10.3.1 Glenmark Pharmaceuticals Ltd. Basic Information
10.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
10.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.3.4 Glenmark Pharmaceuticals Ltd. Business Overview
10.3.5 Glenmark Pharmaceuticals Ltd. SWOT Analysis
10.3.6 Glenmark Pharmaceuticals Ltd. Recent Developments
10.4 Sun Pharmaceuticals
10.4.1 Sun Pharmaceuticals Basic Information
10.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.4.4 Sun Pharmaceuticals Business Overview
10.4.5 Sun Pharmaceuticals Recent Developments
10.5 Actavis Generics
10.5.1 Actavis Generics Basic Information
10.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Overview
10.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Market Performance
10.5.4 Actavis Generics Business Overview
10.5.5 Actavis Generics Recent Developments
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Basic Information
10.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
10.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Market Performance
10.6.4 Dr. Reddy's Laboratories Business Overview
10.6.5 Dr. Reddy's Laboratories Recent Developments
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Basic Information
10.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
10.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.7.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.8 Apotex Inc.
10.8.1 Apotex Inc. Basic Information
10.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Overview
10.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.8.4 Apotex Inc. Business Overview
10.8.5 Apotex Inc. Recent Developments
10.9 Mylan Pharms Inc.
10.9.1 Mylan Pharms Inc. Basic Information
10.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Overview
10.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.9.4 Mylan Pharms Inc. Business Overview
10.9.5 Mylan Pharms Inc. Recent Developments
10.10 Bulat Pharmaceutical
10.10.1 Bulat Pharmaceutical Basic Information
10.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Overview
10.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Market Performance
10.10.4 Bulat Pharmaceutical Business Overview
10.10.5 Bulat Pharmaceutical Recent Developments
10.11 MSN Laboratories
10.11.1 MSN Laboratories Basic Information
10.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
10.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Market Performance
10.11.4 MSN Laboratories Business Overview
10.11.5 MSN Laboratories Recent Developments
10.12 Vannsh Life Sciences
10.12.1 Vannsh Life Sciences Basic Information
10.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Overview
10.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Market Performance
10.12.4 Vannsh Life Sciences Business Overview
10.12.5 Vannsh Life Sciences Recent Developments
10.13 Beacon Pharmaceuticals
10.13.1 Beacon Pharmaceuticals Basic Information
10.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.13.4 Beacon Pharmaceuticals Business Overview
10.13.5 Beacon Pharmaceuticals Recent Developments
10.14 Drug International
10.14.1 Drug International Basic Information
10.14.2 Drug International Gastrointestinal Stromal Tumor Drug Product Overview
10.14.3 Drug International Gastrointestinal Stromal Tumor Drug Product Market Performance
10.14.4 Drug International Business Overview
10.14.5 Drug International Recent Developments
10.15 Deciphera Pharmaceuticals
10.15.1 Deciphera Pharmaceuticals Basic Information
10.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.15.4 Deciphera Pharmaceuticals Business Overview
10.15.5 Deciphera Pharmaceuticals Recent Developments
10.16 CSPC Pharmaceuticals
10.16.1 CSPC Pharmaceuticals Basic Information
10.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.16.4 CSPC Pharmaceuticals Business Overview
10.16.5 CSPC Pharmaceuticals Recent Developments
10.17 Hansoh Pharmaceuticals
10.17.1 Hansoh Pharmaceuticals Basic Information
10.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.17.4 Hansoh Pharmaceuticals Business Overview
10.17.5 Hansoh Pharmaceuticals Recent Developments
10.18 Kelun Pharmaceuticals
10.18.1 Kelun Pharmaceuticals Basic Information
10.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.18.4 Kelun Pharmaceuticals Business Overview
10.18.5 Kelun Pharmaceuticals Recent Developments
10.19 Zai Lab
10.19.1 Zai Lab Basic Information
10.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Product Overview
10.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Product Market Performance
10.19.4 Zai Lab Business Overview
10.19.5 Zai Lab Recent Developments
10.20 CStone Pharmaceuticals
10.20.1 CStone Pharmaceuticals Basic Information
10.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.20.4 CStone Pharmaceuticals Business Overview
10.20.5 CStone Pharmaceuticals Recent Developments
10.21 China Biopharmaceuticals
10.21.1 China Biopharmaceuticals Basic Information
10.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.21.4 China Biopharmaceuticals Business Overview
10.21.5 China Biopharmaceuticals Recent Developments
11 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumor Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor Drug by Type (2026-2035)
12.1.2 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor Drug by Type (2026-2035)
12.2 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal Stromal Tumor Drug Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumor Drug Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumor Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumor Drug Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumor Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumor Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumor Drug Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumor Drug Market Size by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumor Drug Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor Drug Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumor Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumor Drug Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumor Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumor Drug Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumor Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumor Drug Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumor Drug Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumor Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumor Drug by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumor Drug Production
9.4.1 North America Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumor Drug Production
9.5.1 Europe Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumor Drug Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumor Drug Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumor Drug Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumor Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Gastrointestinal Stromal Tumor Drug Product Overview
10.1.3 Novartis Gastrointestinal Stromal Tumor Drug Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer Pharmaceuticals
10.2.1 Bayer Pharmaceuticals Basic Information
10.2.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.2.4 Bayer Pharmaceuticals Business Overview
10.2.5 Bayer Pharmaceuticals SWOT Analysis
10.2.6 Bayer Pharmaceuticals Recent Developments
10.3 Glenmark Pharmaceuticals Ltd.
10.3.1 Glenmark Pharmaceuticals Ltd. Basic Information
10.3.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
10.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.3.4 Glenmark Pharmaceuticals Ltd. Business Overview
10.3.5 Glenmark Pharmaceuticals Ltd. SWOT Analysis
10.3.6 Glenmark Pharmaceuticals Ltd. Recent Developments
10.4 Sun Pharmaceuticals
10.4.1 Sun Pharmaceuticals Basic Information
10.4.2 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.4.4 Sun Pharmaceuticals Business Overview
10.4.5 Sun Pharmaceuticals Recent Developments
10.5 Actavis Generics
10.5.1 Actavis Generics Basic Information
10.5.2 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Overview
10.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Product Market Performance
10.5.4 Actavis Generics Business Overview
10.5.5 Actavis Generics Recent Developments
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Basic Information
10.6.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
10.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Market Performance
10.6.4 Dr. Reddy's Laboratories Business Overview
10.6.5 Dr. Reddy's Laboratories Recent Developments
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Basic Information
10.7.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
10.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.7.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.8 Apotex Inc.
10.8.1 Apotex Inc. Basic Information
10.8.2 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Overview
10.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.8.4 Apotex Inc. Business Overview
10.8.5 Apotex Inc. Recent Developments
10.9 Mylan Pharms Inc.
10.9.1 Mylan Pharms Inc. Basic Information
10.9.2 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Overview
10.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Market Performance
10.9.4 Mylan Pharms Inc. Business Overview
10.9.5 Mylan Pharms Inc. Recent Developments
10.10 Bulat Pharmaceutical
10.10.1 Bulat Pharmaceutical Basic Information
10.10.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Overview
10.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Market Performance
10.10.4 Bulat Pharmaceutical Business Overview
10.10.5 Bulat Pharmaceutical Recent Developments
10.11 MSN Laboratories
10.11.1 MSN Laboratories Basic Information
10.11.2 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
10.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Market Performance
10.11.4 MSN Laboratories Business Overview
10.11.5 MSN Laboratories Recent Developments
10.12 Vannsh Life Sciences
10.12.1 Vannsh Life Sciences Basic Information
10.12.2 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Overview
10.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Market Performance
10.12.4 Vannsh Life Sciences Business Overview
10.12.5 Vannsh Life Sciences Recent Developments
10.13 Beacon Pharmaceuticals
10.13.1 Beacon Pharmaceuticals Basic Information
10.13.2 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.13.4 Beacon Pharmaceuticals Business Overview
10.13.5 Beacon Pharmaceuticals Recent Developments
10.14 Drug International
10.14.1 Drug International Basic Information
10.14.2 Drug International Gastrointestinal Stromal Tumor Drug Product Overview
10.14.3 Drug International Gastrointestinal Stromal Tumor Drug Product Market Performance
10.14.4 Drug International Business Overview
10.14.5 Drug International Recent Developments
10.15 Deciphera Pharmaceuticals
10.15.1 Deciphera Pharmaceuticals Basic Information
10.15.2 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.15.4 Deciphera Pharmaceuticals Business Overview
10.15.5 Deciphera Pharmaceuticals Recent Developments
10.16 CSPC Pharmaceuticals
10.16.1 CSPC Pharmaceuticals Basic Information
10.16.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.16.4 CSPC Pharmaceuticals Business Overview
10.16.5 CSPC Pharmaceuticals Recent Developments
10.17 Hansoh Pharmaceuticals
10.17.1 Hansoh Pharmaceuticals Basic Information
10.17.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.17.4 Hansoh Pharmaceuticals Business Overview
10.17.5 Hansoh Pharmaceuticals Recent Developments
10.18 Kelun Pharmaceuticals
10.18.1 Kelun Pharmaceuticals Basic Information
10.18.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.18.4 Kelun Pharmaceuticals Business Overview
10.18.5 Kelun Pharmaceuticals Recent Developments
10.19 Zai Lab
10.19.1 Zai Lab Basic Information
10.19.2 Zai Lab Gastrointestinal Stromal Tumor Drug Product Overview
10.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Product Market Performance
10.19.4 Zai Lab Business Overview
10.19.5 Zai Lab Recent Developments
10.20 CStone Pharmaceuticals
10.20.1 CStone Pharmaceuticals Basic Information
10.20.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.20.4 CStone Pharmaceuticals Business Overview
10.20.5 CStone Pharmaceuticals Recent Developments
10.21 China Biopharmaceuticals
10.21.1 China Biopharmaceuticals Basic Information
10.21.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
10.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Market Performance
10.21.4 China Biopharmaceuticals Business Overview
10.21.5 China Biopharmaceuticals Recent Developments
11 GASTROINTESTINAL STROMAL TUMOR DRUG MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumor Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor Drug by Type (2026-2035)
12.1.2 Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor Drug by Type (2026-2035)
12.2 Global Gastrointestinal Stromal Tumor Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal Stromal Tumor Drug Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal Stromal Tumor Drug Market Size by Type (M USD)
Table 4. Global Gastrointestinal Stromal Tumor Drug Market Size by Application
Table 5. Gastrointestinal Stromal Tumor Drug Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumor Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal Stromal Tumor Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Drug as of 2025)
Table 11. Global Market Gastrointestinal Stromal Tumor Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal Stromal Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal Stromal Tumor Drug Sales by Type (K MT)
Table 27. Global Gastrointestinal Stromal Tumor Drug Market Size by Type (M USD)
Table 28. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Drug Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumor Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Application
Table 34. Global Gastrointestinal Stromal Tumor Drug Market Size by Application
Table 35. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal Stromal Tumor Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal Stromal Tumor Drug Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal Stromal Tumor Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal Stromal Tumor Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Gastrointestinal Stromal Tumor Drug Product Overview
Table 64. Novartis Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Bayer Pharmaceuticals Basic Information
Table 69. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 70. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bayer Pharmaceuticals Business Overview
Table 72. Bayer Pharmaceuticals SWOT Analysis
Table 73. Bayer Pharmaceuticals Recent Developments
Table 74. Glenmark Pharmaceuticals Ltd. Basic Information
Table 75. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
Table 76. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Glenmark Pharmaceuticals Ltd. Business Overview
Table 78. Glenmark Pharmaceuticals Ltd. SWOT Analysis
Table 79. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 80. Sun Pharmaceuticals Basic Information
Table 81. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 82. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceuticals Business Overview
Table 84. Sun Pharmaceuticals Recent Developments
Table 85. Actavis Generics Basic Information
Table 86. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Overview
Table 87. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Actavis Generics Business Overview
Table 89. Actavis Generics Recent Developments
Table 90. Dr. Reddy's Laboratories Basic Information
Table 91. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
Table 92. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dr. Reddy's Laboratories Business Overview
Table 94. Dr. Reddy's Laboratories Recent Developments
Table 95. Teva Pharmaceutical Industries Ltd. Basic Information
Table 96. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
Table 97. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 100. Apotex Inc. Basic Information
Table 101. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Overview
Table 102. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Apotex Inc. Business Overview
Table 104. Apotex Inc. Recent Developments
Table 105. Mylan Pharms Inc. Basic Information
Table 106. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Overview
Table 107. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Mylan Pharms Inc. Business Overview
Table 109. Mylan Pharms Inc. Recent Developments
Table 110. Bulat Pharmaceutical Basic Information
Table 111. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Overview
Table 112. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bulat Pharmaceutical Business Overview
Table 114. Bulat Pharmaceutical Recent Developments
Table 115. MSN Laboratories Basic Information
Table 116. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
Table 117. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. MSN Laboratories Business Overview
Table 119. MSN Laboratories Recent Developments
Table 120. Vannsh Life Sciences Basic Information
Table 121. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Overview
Table 122. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Vannsh Life Sciences Business Overview
Table 124. Vannsh Life Sciences Recent Developments
Table 125. Beacon Pharmaceuticals Basic Information
Table 126. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 127. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Beacon Pharmaceuticals Business Overview
Table 129. Beacon Pharmaceuticals Recent Developments
Table 130. Drug International Basic Information
Table 131. Drug International Gastrointestinal Stromal Tumor Drug Product Overview
Table 132. Drug International Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Drug International Business Overview
Table 134. Drug International Recent Developments
Table 135. Deciphera Pharmaceuticals Basic Information
Table 136. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 137. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Deciphera Pharmaceuticals Business Overview
Table 139. Deciphera Pharmaceuticals Recent Developments
Table 140. CSPC Pharmaceuticals Basic Information
Table 141. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 142. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. CSPC Pharmaceuticals Business Overview
Table 144. CSPC Pharmaceuticals Recent Developments
Table 145. Hansoh Pharmaceuticals Basic Information
Table 146. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 147. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Hansoh Pharmaceuticals Business Overview
Table 149. Hansoh Pharmaceuticals Recent Developments
Table 150. Kelun Pharmaceuticals Basic Information
Table 151. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 152. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Kelun Pharmaceuticals Business Overview
Table 154. Kelun Pharmaceuticals Recent Developments
Table 155. Zai Lab Basic Information
Table 156. Zai Lab Gastrointestinal Stromal Tumor Drug Product Overview
Table 157. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Zai Lab Business Overview
Table 159. Zai Lab Recent Developments
Table 160. CStone Pharmaceuticals Basic Information
Table 161. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 162. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. CStone Pharmaceuticals Business Overview
Table 164. CStone Pharmaceuticals Recent Developments
Table 165. China Biopharmaceuticals Basic Information
Table 166. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 167. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Biopharmaceuticals Business Overview
Table 169. China Biopharmaceuticals Recent Developments
Table 170. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 171. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 173. North America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 175. Europe Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 177. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 179. South America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 183. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Gastrointestinal Stromal Tumor Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 185. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) Forecast by Application (2026-2035)
Table 186. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal Stromal Tumor Drug Market Size by Type (M USD)
Table 4. Global Gastrointestinal Stromal Tumor Drug Market Size by Application
Table 5. Gastrointestinal Stromal Tumor Drug Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumor Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal Stromal Tumor Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Drug as of 2025)
Table 11. Global Market Gastrointestinal Stromal Tumor Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal Stromal Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal Stromal Tumor Drug Sales by Type (K MT)
Table 27. Global Gastrointestinal Stromal Tumor Drug Market Size by Type (M USD)
Table 28. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Drug Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumor Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) by Application
Table 34. Global Gastrointestinal Stromal Tumor Drug Market Size by Application
Table 35. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal Stromal Tumor Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal Stromal Tumor Drug Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal Stromal Tumor Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal Stromal Tumor Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal Stromal Tumor Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal Stromal Tumor Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal Stromal Tumor Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Gastrointestinal Stromal Tumor Drug Product Overview
Table 64. Novartis Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Bayer Pharmaceuticals Basic Information
Table 69. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 70. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bayer Pharmaceuticals Business Overview
Table 72. Bayer Pharmaceuticals SWOT Analysis
Table 73. Bayer Pharmaceuticals Recent Developments
Table 74. Glenmark Pharmaceuticals Ltd. Basic Information
Table 75. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
Table 76. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Glenmark Pharmaceuticals Ltd. Business Overview
Table 78. Glenmark Pharmaceuticals Ltd. SWOT Analysis
Table 79. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 80. Sun Pharmaceuticals Basic Information
Table 81. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 82. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceuticals Business Overview
Table 84. Sun Pharmaceuticals Recent Developments
Table 85. Actavis Generics Basic Information
Table 86. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Overview
Table 87. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Actavis Generics Business Overview
Table 89. Actavis Generics Recent Developments
Table 90. Dr. Reddy's Laboratories Basic Information
Table 91. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
Table 92. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dr. Reddy's Laboratories Business Overview
Table 94. Dr. Reddy's Laboratories Recent Developments
Table 95. Teva Pharmaceutical Industries Ltd. Basic Information
Table 96. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Overview
Table 97. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 100. Apotex Inc. Basic Information
Table 101. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Overview
Table 102. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Apotex Inc. Business Overview
Table 104. Apotex Inc. Recent Developments
Table 105. Mylan Pharms Inc. Basic Information
Table 106. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Overview
Table 107. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Mylan Pharms Inc. Business Overview
Table 109. Mylan Pharms Inc. Recent Developments
Table 110. Bulat Pharmaceutical Basic Information
Table 111. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Overview
Table 112. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bulat Pharmaceutical Business Overview
Table 114. Bulat Pharmaceutical Recent Developments
Table 115. MSN Laboratories Basic Information
Table 116. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Overview
Table 117. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. MSN Laboratories Business Overview
Table 119. MSN Laboratories Recent Developments
Table 120. Vannsh Life Sciences Basic Information
Table 121. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Overview
Table 122. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Vannsh Life Sciences Business Overview
Table 124. Vannsh Life Sciences Recent Developments
Table 125. Beacon Pharmaceuticals Basic Information
Table 126. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 127. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Beacon Pharmaceuticals Business Overview
Table 129. Beacon Pharmaceuticals Recent Developments
Table 130. Drug International Basic Information
Table 131. Drug International Gastrointestinal Stromal Tumor Drug Product Overview
Table 132. Drug International Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Drug International Business Overview
Table 134. Drug International Recent Developments
Table 135. Deciphera Pharmaceuticals Basic Information
Table 136. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 137. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Deciphera Pharmaceuticals Business Overview
Table 139. Deciphera Pharmaceuticals Recent Developments
Table 140. CSPC Pharmaceuticals Basic Information
Table 141. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 142. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. CSPC Pharmaceuticals Business Overview
Table 144. CSPC Pharmaceuticals Recent Developments
Table 145. Hansoh Pharmaceuticals Basic Information
Table 146. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 147. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Hansoh Pharmaceuticals Business Overview
Table 149. Hansoh Pharmaceuticals Recent Developments
Table 150. Kelun Pharmaceuticals Basic Information
Table 151. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 152. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Kelun Pharmaceuticals Business Overview
Table 154. Kelun Pharmaceuticals Recent Developments
Table 155. Zai Lab Basic Information
Table 156. Zai Lab Gastrointestinal Stromal Tumor Drug Product Overview
Table 157. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Zai Lab Business Overview
Table 159. Zai Lab Recent Developments
Table 160. CStone Pharmaceuticals Basic Information
Table 161. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 162. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. CStone Pharmaceuticals Business Overview
Table 164. CStone Pharmaceuticals Recent Developments
Table 165. China Biopharmaceuticals Basic Information
Table 166. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Overview
Table 167. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Biopharmaceuticals Business Overview
Table 169. China Biopharmaceuticals Recent Developments
Table 170. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 171. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 172. North America Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 173. North America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Europe Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 175. Europe Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 176. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 177. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 178. South America Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 179. South America Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 180. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales Forecast by Country (2026-2035) & (Units)
Table 181. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 182. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 183. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 184. Global Gastrointestinal Stromal Tumor Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 185. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) Forecast by Application (2026-2035)
Table 186. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Stromal Tumor Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumor Drug Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumor Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal Stromal Tumor Drug Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal Stromal Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal Stromal Tumor Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor Drug Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumor Drug
Figure 19. Global Gastrointestinal Stromal Tumor Drug Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumor Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumor Drug Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumor Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumor Drug by Type in 2025
Figure 29. Market Share of Gastrointestinal Stromal Tumor Drug by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal Stromal Tumor Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumor Drug Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal Stromal Tumor Drug Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumor Drug Market Share by Application in 2025
Figure 37. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumor Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumor Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumor Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumor Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumor Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal Stromal Tumor Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal Stromal Tumor Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gastrointestinal Stromal Tumor Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal Stromal Tumor Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal Stromal Tumor Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumor Drug Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumor Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal Stromal Tumor Drug Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal Stromal Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal Stromal Tumor Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor Drug Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumor Drug
Figure 19. Global Gastrointestinal Stromal Tumor Drug Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumor Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumor Drug Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumor Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumor Drug by Type in 2025
Figure 29. Market Share of Gastrointestinal Stromal Tumor Drug by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal Stromal Tumor Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumor Drug Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal Stromal Tumor Drug Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumor Drug Market Share by Application in 2025
Figure 37. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumor Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumor Drug Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumor Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumor Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumor Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumor Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal Stromal Tumor Drug Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumor Drug Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumor Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumor Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumor Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal Stromal Tumor Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumor Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumor Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal Stromal Tumor Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumor Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal Stromal Tumor Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal Stromal Tumor Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal Stromal Tumor Drug Market Share Forecast by Application (2026-2035)
